Clever Culture Systems Limited
CC5
Rang in Aktien
#27512
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Aktienkurs
$0.0141057
Zuletzt synchronisiert: 2026-10-18
Marktkapitalisierung
$30.78M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
32.83%
Land
AU
Handel Clever Culture Systems Limited (CC5)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Clever Culture Systems Limited (CC5)
Anzahl der ausstehenden Aktien zum June 2024: 755.46M
Laut den neuesten Finanzberichten und dem Aktienkurs von Clever Culture Systems Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 755.46M. Am Ende von June 2023 hatte das Unternehmen 471.25M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Clever Culture Systems Limited (CC5) von 2007 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 755.46M | -19.50% |
| 2024 | 938.43M | 99.14% |
| 2023 | 471.25M | 8.13% |
| 2022 | 435.81M | 6.45% |
| 2021 | 409.38M | 21.70% |
| 2020 | 336.38M | 16.15% |
| 2019 | 289.60M | 28.13% |
| 2018 | 226.01M | 23.83% |
| 2017 | 182.52M | 58.80% |
| 2016 | 114.94M | 1.26% |
| 2015 | 113.51M | 13.91% |
| 2014 | 99.65M | -0.23% |
| 2013 | 99.87M | 0.50% |
| 2012 | 99.37M | 0.00% |
| 2011 | 99.37M | 0.18% |
| 2010 | 99.20M | -0.18% |
| 2009 | 99.37M | 0.48% |
| 2008 | 98.90M | -6.05% |
| 2007 | 105.27M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 371.00M | -50.89% |
US
|
|
| 705.30M | -6.64% |
US
|
|
| 143.28M | -81.03% |
US
|
|
| - | - |
CN
|
|
| 282.00M | -62.67% |
US
|
